{
  "url": "https://www.law.cornell.edu/regulations/new-york/10-NYCRR-793.3",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 793.3 - Initial and comprehensive assessment",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 10 ยง 793.3 - Initial and comprehensive assessment\n\nState Regulations\n(a) The hospice\nregistered nurse, as a member of the interdisciplinary group identified in\nsection\n793.4\nof this Part, must complete\nan initial assessment within 48 hours after the election of hospice care in\naccordance with section\n793.2\nof this Part unless the\nphysician, patient, or representative requests that the initial assessment be\ncompleted in less than 48 hours. Initial assessment means an evaluation of the\npatient's physical, psychosocial and emotional status related to the terminal\nillness and related conditions to determine the patient's immediate care and\nsupport needs. (b) The hospice\ninterdisciplinary group, in consultation with the individual's attending\nphysician (if any), shall conduct and document in writing a patient-specific\ncomprehensive assessment no later than five calendar days after the election of\nhospice care. Comprehensive assessment\nmeans a thorough\nevaluation of the patient's physical, psychosocial, emotional and spiritual\nstatus related to the terminal illness and related conditions including the\ncaregiver's and family's willingness and capability to care for the\npatient. (c) The comprehensive\nassessment must take into consideration the following factors: (1)\nthe nature and condition causing\nadmission (including the presence or lack of objective data and subjective\ncomplaints); (2)\ncomplications and\nrisk factors that affect care planning; (3)\nfunctional status, including the\npatient's ability to understand and participate in his or her own\ncare; (4)\nimminence of\ndeath; (5)\nseverity of\nsymptoms; (6)\na review of all of\nthe patient's prescription and over-the-counter drugs, herbal remedies and\nother alternative treatments that could affect drug therapy. This includes, but\nis not limited to, identification of the following: (i) effectiveness of drug therapy; (ii)\ndrug side effects; (iii)\nactual or potential drug\ninteractions; (iv)\nduplicate drug\ntherapy; and\n(v) drug therapy\ncurrently associated with laboratory monitoring; (7)\nan initial bereavement assessment of the\nneeds of the patient's family and other individuals focusing on the social, spiritual, and cultural factors that may impact their ability to cope with the\npatient's death. Information gathered from the initial bereavement assessment\nmust be incorporated into the plan of care and considered in the bereavement\nplan of care; and\n(8)\nthe need for\nreferrals and further evaluation by appropriate health professionals. (d) The comprehensive assessment\nmust include data elements that allow for measurement of outcomes. The data\nelements must: (1)\ntake into consideration\naspects of care related to hospice and palliation; (2)\nbe measured and documented in the same\nway for all patients; (3)\nbe an\nintegral part of the comprehensive assessment and documented in a systematic\nand retrievable way for each patient; (4)\nbe used in individual patient care\nplanning and in the coordination of services; and\n(5)\nbe used in the aggregate for the\nhospice's quality assessment and performance improvement program. (e) The hospice interdisciplinary\ngroup must update the comprehensive assessment in collaboration with the\nindividual's attending physician, if any, as frequently as the condition of the\npatient requires, but no less frequently than every 15 days. The update must\nconsider changes that have taken place since the initial assessment and include\ninformation on the patient's progress toward desired outcomes, as well as a\nreassessment of the patient's response to care. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 10\nยง\n793.3\n\nAmended\n\nNew\n\nYork State Register August 31, 2016/Volume XXXVIII, Issue 35, eff. 8/31/2016\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 51112
}